EN
HI
Alembic Pharmaceuticals share price chart
Alembic Pharmaceuticals Share Key Metrics
Volume
2.44 L
Market Cap
16082.79 CR
LTQ@LTP
3@818.20
ATP
829.32
Var Margin
15.93 %
Circuit Range
647.55-971.25
Delivery %
26.18 %
Value
20.20 CR
ASM/GSM
No
Market Lot
1
Summary
APLLTD stock price is ₹818.2 as of 5 Aug, 2026. The stock intraday movement has stayed between ₹803.20 and ₹840.40, while Alembic Pharmaceuticals share price 52 week high low is ₹635.80 & ₹1004.80.
In terms of trading activity, APLLTD share price has recorded a volume of 2,43,621 shares. The Alembic Pharmaceuticals has a market cap of ₹196563124. The stock’s Average Traded Price (ATP) stands at ₹829.32, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 3 @ ₹818.20.
The Alembic Pharmaceuticals upper circuit limit is ₹971.25 & The Alembic Pharmaceuticals lower circuit limit is ₹647.55, with a Value of ₹20.20 CR. The Delivery Percentage for the day is 26.18%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Alembic Pharmaceuticals Fundamentals
P/E Ratio
22.95
P/B Ratio
2.8
Div. Yield
1.48
Sector P/E
64.89
Sector P/B
3.24
Sec. Div. Yield
0.52
Alembic Pharmaceuticals Resistance and Support
Pivot 811.17
Resistance
First Resistance
823.24
Second Resistance
837.07
Third Resistance
849.14
Support
First Support
797.34
Second Support
785.27
Third Support
771.44
Alembic Pharmaceuticals Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Wed Aug 05 2026 | 822 | 818.2 | 1.09% | 840.4 | 803.2 |
| Tue Aug 04 2026 | 805.75 | 809.4 | 0.45% | 825 | 799.09 |
| Mon Aug 03 2026 | 797.04 | 805.75 | 1.09% | 815.04 | 792.54 |
Alembic Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-04 | Quarterly Results |
| 2026-05-15 | Audited Results & Final Dividend |
| 2026-02-05 | Quarterly Results |
| 2025-11-04 | Quarterly Results & Others |
| 2025-08-05 | Quarterly Results & Others |
| 2025-05-06 | Audited Results & Final Dividend |
| 2025-02-03 | Quarterly Results & Others |
| 2024-11-07 | Quarterly Results |
| 2024-08-08 | Quarterly Results |
Alembic Pharmaceuticals News
Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)
Alembic Pharma reported strong Q1 FY27 consolidated financial results. Revenue increased 26% YoY to Rs. 2150 cr, and net profit grew 12% YoY to Rs. 173 cr, reflecting broad-based business growth.
Aug 04 2026 14:51:46
Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Alembic Pharma reported strong Q1 FY27 results, with revenue up 26% YoY to Rs.2,150 cr and net profit up 12% YoY to Rs.173 cr. EBITDA increased 21% YoY to Rs.523 cr.
Aug 04 2026 14:20:51
Read More
Alembic Pharmaceuticals Management
| Name | Position |
|---|---|
| Chirayu Amin | Chairman & CEO |
| Pranav Amin | Managing Director |
Alembic Pharmaceuticals Similar Stocks
Astrazeneca Pharma India Ltd.
8108.50
-102.00 (1.24%)
Onesource Specialty Pharma Ltd.
1553.70
23.10 (1.51%)
Poly Medicure Ltd.
1708.50
-16.00 (0.93%)
Natco Pharma Ltd.
917.55
0.55 (0.06%)
Cohance Lifesciences Ltd.
429.45
4.55 (1.07%)
Rainbow Children's Medicare Ltd.
1598.60
19.60 (1.24%)
Dr. Agarwal's Health Care Ltd.
521.05
27.55 (5.58%)
Jubilant Pharmova Ltd.
924.70
-8.05 (0.86%)
Concord Biotech Ltd.
1385.00
-35.00 (2.46%)
Alembic Pharmaceuticals FAQs
The Buying Price of Alembic Pharmaceuticals share is 818.2 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Alembic Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Alembic Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Alembic Pharmaceuticals shares is 22.95. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Alembic Pharmaceuticals shares is 2.8. Useful to assess the stock's value relative to its book value.
To assess Alembic Pharmaceuticals’s valuation compare Sector P/E, P/B which are 64.89 & 3.24 with sector averages, along with growth rates and financial metrics.
The Market Cap of Alembic Pharmaceuticals is 16082.79 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Alembic Pharmaceuticals share price is 1004.80 & 635.80. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Alembic Pharmaceuticals belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
